Related Experiment Video
Updated: Feb 22, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Gene selection tool (GST): A R-based tool for genetic disorders based on the sliding-window proportion test using
Sugi Lee1,2, Minah Jung1,2, Jaeeun Jung1,2
1Department of Bioinformatics, KRIBB School of Bioscience, Korea University of Science and Technology(UST), Daejeon, Korea.
This study introduces a new tool to improve the accuracy of whole-exome sequencing (WES) for identifying genetic causes of hereditary diseases. The gene selection tool (GST) effectively reduces false positives in WES data, aiding in disease gene discovery.
Area of Science:
- Genetics
- Bioinformatics
- Medical Genomics
Background:
- Whole-exome sequencing (WES) is crucial for identifying causative mutations in hereditary diseases.
- WES data often contains numerous false positives and shared variants within families, complicating variant selection.
- Accurate identification of disease-associated variants is essential for genetic diagnosis and research.
Purpose of the Study:
- To develop a novel computational tool for enhancing the accuracy of variant analysis in whole-exome sequencing data.
- To reduce false positives and improve the selection of disease-causing genes from complex WES datasets, particularly in familial studies.
- To create a sensitive and efficient method for linkage analysis using multilocus variants.
Main Methods:
- Developed the Gene Selection Tool (GST), an R-coded program utilizing proportion tests for linkage analysis.
- Employed a sliding-window approach to analyze multilocus variants within specific genomic regions, moving beyond single-nucleotide variants (SNVs).
- Applied the GST to whole-exome sequencing data from a family with hereditary spastic paraplegia.
Main Results:
- The GST demonstrated high sensitivity in identifying disease-associated genes.
- Successfully identified the known causative gene for hereditary spastic paraplegia within the analyzed family.
- The analysis also highlighted other potential candidate genes associated with the disease, expanding the scope of discovery.
Conclusions:
- The developed Gene Selection Tool (GST) significantly improves the accuracy of variant interpretation in whole-exome sequencing data.
- This approach effectively addresses challenges posed by false positives and shared variants in familial genetic studies.
- The GST facilitates more precise identification of disease genes and offers potential for discovering novel genetic associations.
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...